Intraventricular hemorrhage in preterm infants: A systematic review of risk- and outcome-prediction models
Clinical Snapshot
PICO Framework
| P — Population | Preterm infants at risk of or diagnosed with intraventricular hemorrhage (IVH) |
| I — Intervention | Prediction models for IVH risk or outcomes — including regression-based and machine learning models incorporating perinatal clinical variables, physiologic/hemodynamic indices, serum biomarkers, IVH grade, comorbidities, and neuroimaging markers |
| C — Comparator | No single universal comparator; studies compared model performance against each other or against clinical judgment, with varying reference standards for IVH diagnosis and outcome classification |
| O — Outcomes | Primary: discrimination and calibration performance of IVH risk-prediction models (e.g., AUC/C-statistic). Secondary: prediction of short- and long-term neurodevelopmental outcomes in preterm infants with IVH; model validation (internal and external) |
Bottom Line
This systematic review synthesises 45 years of literature on prediction models for intraventricular hemorrhage (IVH) in preterm infants, identifying 40 studies across risk-prediction and outcome-prediction domains. The review confirms that IVH severity grade is the most robust and consistent predictor of adverse neurodevelopmental outcomes, and that machine learning approaches show superior discrimination to regression models when applied to larger datasets. However, the clinical translation of these findings is substantially limited. Most models suffer from small single-centre samples, heterogeneous predictor definitions, inconsistent measurement timing, and — critically — infrequent reporting of calibration statistics and external validation. No model is ready for routine clinical implementation. For Australian neonatologists, the review reinforces that existing prevention strategies (antenatal corticosteroids, magnesium sulphate) remain the evidence-based priority. The ANZNN infrastructure represents an underutilised opportunity for the multicenter, externally validated model development that this review identifies as the essential next step. Clinicians should treat currently published IVH prediction models as exploratory research tools rather than decision-support instruments, and await prospective validation studies before incorporating any model into clinical practice or family counselling frameworks.
Key Findings
P Value: Not applicable to this narrative systematic review format
Effect Size: No pooled effect size reported. Narrative synthesis indicates most models performed 'acceptably'; machine learning models demonstrated better discrimination than regression models in larger datasets. IVH severity (grade) was the most consistent predictor across all outcome-prediction models.
Primary Outcome: Performance of IVH risk-prediction and outcome-prediction models in preterm infants, assessed narratively across 40 included studies
Nnt Or Sensitivity: Individual model discrimination statistics (AUC/C-statistic) are referenced narratively but not pooled. Calibration statistics were infrequently reported across included studies. Sensitivity and specificity values for individual models are not summarised in the abstract.
Confidence Interval: Not reported; no meta-analytic pooling was performed
Clinical Application
No specific prediction model is currently recommended for routine clinical implementation based on this review. The review identifies that existing models require external validation and calibration assessment before clinical deployment. Feasibility of future models will depend on standardisation of predictor timing, accessibility of biomarker assays, and integration into electronic medical record systems. IVH remains a significant cause of neonatal mortality and neurodevelopmental disability in Australian NICUs. The Australian and New Zealand Neonatal Network (ANZNN) collects standardised data on IVH in preterm infants, providing an existing infrastructure for multicenter model development and validation — directly addressing the gaps identified by this review. The RACGP and RACP do not currently endorse specific IVH prediction tools for clinical use. No TGA-approved predictive diagnostic device for IVH risk currently exists in Australia. PBS-listed interventions targeting IVH prevention (e.g., antenatal corticosteroids, magnesium sulphate for neuroprotection) remain the standard of care. This review supports the case for ANZNN-leveraged Australian validation studies of promising international prediction models before local clinical adoption. Preterm infants admitted to neonatal intensive care units, particularly those at highest risk of IVH (gestational age <32 weeks, extremely low birthweight). Clinicians involved in antenatal counselling, delivery room management, and NICU prognostication for families of preterm infants with IVH.
Abstract
Intraventricular hemorrhage (IVH) is a major complication of prematurity and one of the top causes of mortality and neurodevelopmental impairment. We conducted a systematic review of PubMed, Scopus, and Web of Science (From 1980 to 2025), identifying 40 studies evaluating prediction models (regression and machine learning) for risk of IVH occurrence and short- and long-term outcomes in preterm infants with IVH. Across these published studies, IVH risk prediction models included combinations of perinatal clinical variables, physiologic and hemodynamic indices, and serum biomarkers. Outcome-prediction models likewise varied. IVH grade was commonly included, with varying inclusion of comorbidities and neuroimaging-based injury markers. Most models performed acceptably, with machine-learning models showing better discrimination in larger datasets. However, the generalizability of the models is limited by heterogeneity in predictors, limited sample sizes, and inconsistent timing of predictor measurements. IVH severity remained the most consistent predictor across all outcome-prediction models. Despite promising performance assessments, clinical relevance is limited due to the infrequent reporting of model calibration, internal validation, and external validation. Future research that standardizes predictor definitions, leverages multicenter cohorts, and ensures thorough validation can advance early IVH risk and outcome-prediction models, thereby meaningfully improving clinical relevance and neonatal care.
References
- 1.Shukla, V. V., Wen, J., & Carlo, W. A. (2026). Intraventricular hemorrhage in preterm infants: A systematic review of risk- and outcome-prediction models. Seminars in Fetal & Neonatal Medicine, 101725. https://doi.org/10.1016/j.siny.2026.101725
Related Research
Indian journal of pediatrics
Emerging Applications of Artificial Intelligence in Pediatric Care
2 Aug 2026
JAMA
Prone Positioning in Infants With Acute Bronchiolitis: The PROPOSITIS Randomized Clinical Trial
30 July 2026
Pediatric surgery international
ARM in ARM? Investigating the co-occurrence of anorectal malformations and labioscrotal anomalies.
20 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service